切换导航
关闭
  • 菜单
  • Setting

LY2835219 free base

玻玛西林
Catalog No.
A3575
CDK抑制剂
组合的产品项目
规格价格库存 数量
5mg
¥ 545.00
现货
25mg
¥ 818.00
现货
100mg
¥ 1,363.00
现货

电话: 021-55669583

邮箱: sales@apexbio.cn

全球经销商

A

背景

LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. CDK4/6 dual inhibitor LY2835219 specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation in early G1. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S phase transition, thereby arresting the cell cycle in the G1 phase, suppressing DNA synthesis and inhibiting cancer cell growth. Overexpression of the serine/threonine kinases CDK4/6, as seen in certain types of cancer, causes cell cycle deregulation.

化学属性

Physical AppearanceA solid
StorageStore at -20°C
M.Wt506.59
Cas No.1231929-97-7
FormulaC27H32F2N8
SynonymsCDK4/6 dual inhibitor;LY 2835219 (free base);LY-2835219 (free base)
Solubilityinsoluble in H2O; ≥4.83 mg/mL in DMSO with gentle warming and ultrasonic; ≥6.34 mg/mL in EtOH with gentle warming
Chemical NameN-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-amine
SDFDownload SDF
Canonical SMILESCCN1CCN(CC2=CN=C(NC3=NC=C(F)C(C4=CC5=C(N=C(C)N5C(C)C)C(F)=C4)=N3)C=C2)CC1
运输条件 蓝冰运输或根据您的需求运输。
一般建议不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。

质量控制